» Articles » PMID: 18084647

Aluminium Blunts the Proliferative Response and Increases Apoptosis of Cultured Human Cells: Putative Relationship to Alzheimer's Disease

Overview
Journal Bioinformation
Specialty Biology
Date 2007 Dec 18
PMID 18084647
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aluminium (Al) has been investigated as a neurotoxic substance. Al ranks among the potential environmental risk factors for Alzheimer's disease (AD). Epidemiological studies tested the relationship between Al in drinking water and AD, showing a significant correlation between elevated levels of monomeric Al in water and AD, although data to date remain inconclusive with respect to total Al. The aim of this study was to test whether or not Al exacerbates cellular toxicity mediated by the amyloid beta (Abeta) peptide. We evaluated the role of Al in modulating programmed cell death (apoptosis) in human cell cultures. We used the osteosarcoma cell line monolayer (SaOs-2) to demonstrate that treatment of SaOs-2 cultures with the Abeta peptide mid-fragment (25 to 35) at nano M, followed by co-incubation with physiological concentrations of aluminium chloride, which release monomeric Al in solution, led to marked expression of caspase 3, but not caspase 9, key markers of the apoptotic process. The same experimental conditions were shown to blunt significantly the proliferative response of normal human peripheral blood mononuclear cells (PBMC) to phytohemagglutinin (PHA) stimulation. Our observations support the hypothesis that Al significantly impairs certain cellular immune responses, and confirm that Al-mediated cell toxicity may play an important role in AD.

Citing Articles

Folic Acid Protected Neural Cells Against Aluminum-Maltolate-Induced Apoptosis by Preventing miR-19 Downregulation.

Zhu M, Li B, Ma X, Huang C, Wu R, Zhu W Neurochem Res. 2016; 41(8):2110-8.

PMID: 27113042 DOI: 10.1007/s11064-016-1926-9.


Accelerated tau aggregation, apoptosis and neurological dysfunction caused by chronic oral administration of aluminum in a mouse model of tauopathies.

Oshima E, Ishihara T, Yokota O, Nakashima-Yasuda H, Nagao S, Ikeda C Brain Pathol. 2013; 23(6):633-44.

PMID: 23574527 PMC: 8028981. DOI: 10.1111/bpa.12059.

References
1.
Levesque L, Mizzen C, McLachlan D, Fraser P . Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes. Brain Res. 2000; 877(2):191-202. DOI: 10.1016/s0006-8993(00)02637-8. View

2.
Itzhaki R . Possible factors in the etiology of Alzheimer's disease. Mol Neurobiol. 1994; 9(1-3):1-13. DOI: 10.1007/BF02816099. View

3.
Atwood C, Moir R, Huang X, Scarpa R, Bacarra N, Romano D . Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998; 273(21):12817-26. DOI: 10.1074/jbc.273.21.12817. View

4.
Chiappelli F, Manfrini E, Gwirtsman H, Garcia C, Pham L, Lee P . Steroid receptor-mediated modulation of CD4+CD62L+ cell homing. Implications for drug abusers. Ann N Y Acad Sci. 1994; 746:421-5. DOI: 10.1111/j.1749-6632.1994.tb39274.x. View

5.
Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D . Aluminum forms in drinking water and risk of Alzheimer's disease. Environ Res. 2000; 84(3):234-46. DOI: 10.1006/enrs.2000.4101. View